SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹115 Cr | ₹100 Cr | ₹99 Cr | ₹72 Cr | ₹6,343,119 Cr |
What is the latest Total Expenditure of SAKAR HEALTHCARE ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹115 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹99 Cr |
| Mar2022 | ₹72 Cr |
| Mar2021 | ₹6,343,119 Cr |
How is Total Expenditure of SAKAR HEALTHCARE Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹115 Cr | 14.86 | |
| Mar2024 | ₹100 Cr | 1.22 | |
| Mar2023 | ₹99 Cr | 37.10 | |
| Mar2022 | ₹72 Cr | -100.00 | |
| Mar2021 | ₹6,343,119 Cr | - | |
Compare Total Expenditure of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,156.7 Cr | 5.4% | 31.3% | 119.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,217.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,047.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,872.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 5.4% |
31.3% |
119.7% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses